A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.
Publication of Interim Results and Presentation at Recent Industry Event Demonstrate Clinical Benefit Associated with Use of ...
University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder ...
MedPage Today on MSN
Rapid-Acting Drug for Major Heart Attacks Hits Main Goal in Trial
NEW ORLEANS -- Patients experiencing major heart attacks had a lower risk of serious complications if they received a single ...
Group announced the publication of interim results from its CAMPAIGN trial, a randomized controlled trial designed to evaluate the ...
A new phase 1 randomized controlled trial finds that a single dose of the ChAdox1 Rift Valley fever (RVF) vaccine appears ...
Penumbra, Inc. (NYSE: PEN) announced additional results of the ground-breaking STORM-PE randomized controlled trial (RCT), ...
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial Patients with advanced lung cancer reporting at least moderate ...
Daily or weekly bathing? A UK eczema trial finds no difference in symptoms, helping people choose what works best for their ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback